Freshpet Lifts 2026 Outlook on 15.5% Q2 Sales Growth and Expanding Margins
FRPT sits 41% above its 52-week low of $46.45.
Summary
Freshpet reported Q2 2026 net sales of $305.6M (+15.5% YoY) and raised full-year guidance for sales growth and Adjusted EBITDA. The company also lifted its long-term Adjusted Gross Margin target to >49%.
Key Events · Earnings and Guidance · FRPT
-
Q2 Sales Up 15.5%
Net sales reached $305.6 million, driven by 15.7% volume growth, partially offset by 0.2% unfavorable price/mix.
-
Adjusted EBITDA Jumps 17.6%
Adjusted EBITDA rose to $52.2 million from $44.4 million a year ago, with margin expanding 30 bps to 17.1%.
-
Full-Year Guidance Raised
2026 net sales growth now seen at 10-12% (up from 8-11%) and Adjusted EBITDA at $210-220 million (up from $205-215 million).
-
Long-Term Margin Target Lifted
Adjusted Gross Margin target raised to >49% from >48%, supported by new bag technology expected to add ~100 bps annually.
Analysis · FRPT · Manufacturing
A strong second quarter saw net sales climb 15.5% to $305.6 million, while Adjusted EBITDA advanced to $52.2 million. Reflecting this momentum, management raised full-year 2026 guidance for both sales growth and Adjusted EBITDA, and lifted the long-term Adjusted Gross Margin target to above 49%. The results underscore accelerating volume-driven growth, improving operating leverage, and a solid balance sheet with $350.8 million in cash. Even against a backdrop of recent insider selling, the raised guidance and margin targets signal confidence in sustained demand and operational efficiency gains.
At the time of this filing, FRPT was trading at $65.30 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $46.45 to $86.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.